Global Cord Blood P/E Ratio

Global Cord Blood (CO) currently reports a P/E ratio of 1.54. That is below the Healthcare sector average of 77.98. Use the charts on this page to explore Global Cord Blood's P/E ratio history and peer comparisons.

Global Cord Blood's P/E ratio of 1.54 is lower than the Healthcare sector average of 77.98. That is roughly 98.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Global Cord Blood's market price to a fundamental measure such as earnings, sales, or book value. At 1.54, CO can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of 1.54, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 77.98. From there, open related valuation or income-statement pages for Global Cord Blood, and consider following CO for alerts when major investors trade the stock.

Global Cord Blood is classified in the Healthcare sector. On P/E ratio, it currently shows 1.54 versus a sector average near 77.98. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CO with unrelated industries.